Oct 13, 2025 · Entyvio is used to treat moderately to severely active ulcerative colitis (UC) or Crohn's disease in adults. It may help reduce symptoms, achieve remission, and reduce the …

Apr 16, 2025 · Vedolizumab is the generic name for Entyvio, a biologic therapy used to treat moderate to severe Crohn’s disease and ulcerative colitis.

Oct 20, 2025 · Is Entyvio an immunosuppressant drug? No, Entyvio is a gut-selective biologic that modulates the immune system specifically in the gastrointestinal tract, without broadly …

Vedolizumab is a prescription medication used for the treatment of ulcerative colitis and Crohn's disease. Learn about this generic drug, uses, side effects, dosages, drug interactions, and …

ENTYVIO is a biologic treatment for moderate to severe Crohn's disease (CD) or ulcerative colitis (UC). See Safety and Prescribing Information.

Jul 31, 2024 · Find patient medical information for Entyvio (vedolizumab) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Jun 3, 2025 · Learn about Entyvio (vedolizumab) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.

Oct 23, 2024 · Learn about the side effects, dosage, and more of Entyvio (vedolizumab) infusions and injections. It's a prescription drug that treats inflammatory bowel disease (IBD).

Jul 16, 2025 · Entyvio (generic name: vedolizumab) is a biologic therapy approved for the treatment of ulcerative colitis and Crohn’s disease. Entyvio works by preventing too many …

If you are taking a biologic therapy, such as infliximab (Remicade®), adalimumab (Humira®), vedolizumab (Entyvio®), or ustekinumab (Stelara®), to treat inflammatory bowel disease …